Semax: Focus, Memory, and Neuroprotection — The Clinical Science

Semax is a synthetic analogue of the ACTH fragment 4-7, approved in Russia as a pharmaceutical agent for neurological indications. Its primary studied effects relate to cognitive enhancement, neuroprotection, and the regulation of brain-derived neurotrophic factor.

By UAE Peptide Clinic Research Desk

Semax is a synthetic analogue of the adrenocorticotropic hormone (ACTH) fragment 4-7, developed in Russia in the 1980s and approved there as a pharmaceutical agent for neurological indications. Its primary studied effects relate to cognitive enhancement, neuroprotection, and the regulation of brain-derived neurotrophic factor — making it one of the few peptides with direct applications in mental performance and neurological health.

Mechanism of Action

Semax modulates BDNF (brain-derived neurotrophic factor) expression more potently than almost any other known peptide or small molecule. BDNF is the primary growth factor for neurons — it supports the survival of existing neurons, promotes the growth of new connections, and plays a central role in learning, memory, and mood regulation. Semax also influences dopaminergic and serotonergic systems, and has demonstrated anti-inflammatory effects in the central nervous system.

Clinical Applications

In Russia, Semax is approved for use in ischaemic stroke, optic nerve disease, and peptic ulcer disease. In longevity medicine contexts, it is used for cognitive enhancement (focus, working memory, mental stamina), neuroprotection in high-stress environments, and mood support. It is administered as a nasal spray, with the intranasal route providing direct access to the central nervous system via olfactory transport.

Semax is available as a nasal spray through UAE Peptide Clinic. Our physicians will review your neurological health profile and cognitive goals before recommending a protocol. Explore it at /peptides/semax or book a consultation at /book.